Bicocca Open Archive

Logo unimib boa

Pioltelli, M., Pungolino, E., D'Adda, M., Elena, C., Borin, L., Perego, A., et al. (2018). Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up. Intervento presentato a: 60th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 01-04, 2018, San Diego, CA [10.1182/blood-2018-99-113496].

Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up

Cairoli R
2018
paper
Hematology
English
60th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 01-04, 2018
2018
BLOOD
2018
132
S1
5435
none
Pioltelli, M., Pungolino, E., D'Adda, M., Elena, C., Borin, L., Perego, A., et al. (2018). Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up. Intervento presentato a: 60th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 01-04, 2018, San Diego, CA [10.1182/blood-2018-99-113496].
02 - Intervento a convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/409417
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact